Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
BMS $35 million investment in Immatics
We advised Immatics on the private placement of ordinary shares
Upgrade $100 million acquisition of Uplift
We advised Upgrade on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Chase Corporation $1.3 billion acquisition by KKR
We are advising Chase Corporation on the transaction
ODDITY Tech $424 million IPO
The shares are listed on the Nasdaq Global Market
Azul $862 million exchange offers and consent solicitations
The exchange offer included the issuance of the senior secured notes due 2029 and 2030
TPG acquisition of Forcepoint G2CI from Francisco Partners
We are advising TPG on the acquisition
Centogene strategic collaboration with Lifera
We are advising Centogene on its joint venture with and convertible debt investment by Lifera
Noile-Immune Biotech ¥3.1 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Shutterfly $200 million new-money financing and exchange
We are advising an ad hoc group of lenders and noteholders backstopping the financing and participating in the exchange